Innovation Pharmaceuticals Inc (IPIX)

[Golfguru03]

Interesting take-away from that article:


Separately, the U.K. announced it will begin the world’s first human challenge trials — or purposely infecting individuals with Covid-19— early next year. The government-funded trial includes 2,000 potential volunteers, and relies on Gilead Sciences’ (GILD) antiviral remdesivir to manage any negative reactions. Remdesivir has been the only antiviral to-date to receive emergency use authorization against the virus in the U.S.

I would think adding Brilacidin to Remdesivir (as tests have shown) to improve the safety profile for this trial would be a prudent idea.

Mark